SAM
ALDR
Sectoral Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-128,300
| Closed | -$1.32M | – | 116 |
|
|
2018
Q4 | $1.32M | Sell |
128,300
-481,312
| -79% | -$4.93M | 0.18% | 61 |
|
|
2018
Q3 | $10.2M | Sell |
609,612
-429,288
| -41% | -$7.15M | 1.08% | 35 |
|
|
2018
Q2 | $16.4M | Buy |
1,038,900
+175,300
| +20% | +$2.77M | 1.84% | 23 |
|
|
2018
Q1 | $11M | Buy |
+863,600
| New | +$11M | 1.2% | 30 |
|
|
2017
Q2 | – | Sell |
-713,119
| Closed | -$14.8M | – | 70 |
|
|
2017
Q1 | $14.8M | Buy |
713,119
+43,768
| +7% | +$910K | 1.73% | 24 |
|
|
2016
Q4 | $13.9M | Buy |
669,351
+132,230
| +25% | +$2.75M | 1.54% | 25 |
|
|
2016
Q3 | $17.6M | Buy |
537,121
+11,900
| +2% | +$390K | 1.73% | 26 |
|
|
2016
Q2 | $13.1M | Sell |
525,221
-765,932
| -59% | -$19.1M | 1.35% | 28 |
|
|
2016
Q1 | $31.6M | Buy |
1,291,153
+356,202
| +38% | +$8.72M | 1.53% | 20 |
|
|
2015
Q4 | $30.9M | Buy |
934,951
+172,269
| +23% | +$5.69M | 1.32% | 23 |
|
|
2015
Q3 | $25M | Buy |
762,682
+79,946
| +12% | +$2.62M | 1.14% | 24 |
|
|
2015
Q2 | $36.2M | Sell |
682,736
-389,701
| -36% | -$20.6M | 1.51% | 20 |
|
|
2015
Q1 | $31M | Buy |
1,072,437
+968,137
| +928% | +$27.9M | 1.18% | 29 |
|
|
2014
Q4 | $3.03M | Buy |
104,300
+15,000
| +17% | +$436K | 0.14% | 54 |
|
|
2014
Q3 | $1.13M | Buy |
89,300
+48,775
| +120% | +$618K | 0.05% | 63 |
|
|
2014
Q2 | $813K | Buy |
+40,525
| New | +$813K | 0.03% | 61 |
|